Geode Capital Management
NAUT icon

Geode Capital Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Geode Capital Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Buy
1,265,535
+662,011
+110% +$1.75M ﹤0.01% 3155
2026
Q1 		$2.34M Buy
603,524
+42,615
+8% +$105K ﹤0.01% 3066
2025
Q4 		$1.09M Buy
560,909
+7,307
+1% +$12K ﹤0.01% 3348
2025
Q3 		$468K Hold
553,602
– – ﹤0.01% 3650
2025
Q2 		$401K Sell
553,602
-597,420
-52% -$449K ﹤0.01% 3625
2025
Q1 		$991K Buy
1,151,022
+8,480
+0.7% +$12.6K ﹤0.01% 3307
2024
Q4 		$1.92M Buy
1,142,542
+7,000
+0.6% +$16.7K ﹤0.01% 3142
2024
Q3 		$3.24M Buy
1,135,542
+811
+0.1% +$2.1K ﹤0.01% 2958
2024
Q2 		$2.66M Buy
1,134,731
+27,780
+3% +$72.5K ﹤0.01% 3036
2024
Q1 		$3.25M Buy
1,106,951
+41,697
+4% +$118K ﹤0.01% 2913
2023
Q4 		$3.19M Buy
1,065,254
+50,687
+5% +$145K ﹤0.01% 2919
2023
Q3 		$3.21M Buy
1,014,567
+8,101
+0.8% +$26.4K ﹤0.01% 2868
2023
Q2 		$3.9M Buy
1,006,466
+12,780
+1% +$36.8K ﹤0.01% 2826
2023
Q1 		$2.75M Buy
993,686
+32,818
+3% +$68.8K ﹤0.01% 2902
2022
Q4 		$1.73M Buy
960,868
+5,799
+0.6% +$11.2K ﹤0.01% 3109
2022
Q3 		$2.02M Buy
955,069
+4,290
+0.5% +$10.8K ﹤0.01% 3078
2022
Q2 		$2.56M Buy
950,779
+424,473
+81% +$1.58M ﹤0.01% 3027
2022
Q1 		$2.28M Buy
526,306
+31,108
+6% +$128K ﹤0.01% 3196
2021
Q4 		$2.56M Buy
495,198
+109,327
+28% +$585K ﹤0.01% 3256
2021
Q3 		$2.37M Buy
385,871
+320,474
+490% +$2.55M ﹤0.01% 3274
2021
Q2 		$660K Buy
+65,397
New +$708K ﹤0.01% 3808

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management's NAUT Position: Q2 2026 in Review

Geode Capital Management increased its Nautilus Biotechnolgy (NAUT) stake by 110% in Q2 2026, buying an estimated $1.75M and bringing the position to 1,265,535 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #3155.

Geode Capital Management first reported a position in NAUT in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.9M in Q2 2023. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Geode Capital Management held 1,265,535 shares of Nautilus Biotechnolgy worth $2.37M as of Q2 2026.
  • Geode Capital Management bought 662,011 Nautilus Biotechnolgy shares in Q2 2026, an estimated $1.75M.
  • Nautilus Biotechnolgy made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3155 holding.
  • Geode Capital Management first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Nautilus Biotechnolgy position peaked at $3.9M in Q2 2023.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.